Glimepiride
Indication
Type 2 diabetes
Green
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
The LSCMMG recommends glimepiride as the 2nd line sulfonylurea (1st line — gliclazide)
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: